A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern Province
NCT00844467 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2009-02-16
Summary
The purpose of this study is to establish retrospectively the incidence rates of invasive pneumococcal disease in children aged less than 5 years. The investigators allocate the El Hasa region for the study because it has higher incidence of sickle cell anemia. The study will include data from 2003 to 2007(before introduction of the vaccine) and then for 2008 and 2009 (after introduction of the vaccine).
Conditions
- Pneumococcal Infection
Interventions
- BIOLOGICAL
-
serotypes and resistance
screening patients with invasive pneumococci
Sponsors & Collaborators
-
King Saud University
lead OTHER
Eligibility
- Min Age
- 3 Months
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2009-10-31
- Completion
- 2009-12-31
More Related Trials
-
Pneumococcal Conjugate Vaccine Followup
NCT01414504 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants
NCT03512288 ·Status: COMPLETED ·Phase: PHASE2
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
NCT04382326 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants
NCT00444457 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease
NCT00918580 ·Status: COMPLETED ·Phase: PHASE3
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants
NCT04546425 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics
NCT00836641 ·Status: COMPLETED ·Phase: PHASE4
-
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants
NCT04379713 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
NCT04078997 ·Status: COMPLETED
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
NCT04530838 ·Status: COMPLETED ·Phase: PHASE3
-
Child Pneumococcal Serotype Epidemiology In Greece
NCT01111214 ·Status: COMPLETED
-
Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People
NCT04945681 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
Pneumoniae Epidemiology Study in China
NCT00471770 ·Status: COMPLETED
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil
NCT00676091 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Pneumococcal Vaccine in Healthy Infants
NCT00205803 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
NCT01619462 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
NCT00574795 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine
NCT06608199 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age
NCT04642079 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months
NCT06622109 ·Status: ACTIVE_NOT_RECRUITING
-
Pneumococcal Vaccination of Fiji Infants
NCT00170612 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population
NCT00327665 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
NCT03489018 ·Status: COMPLETED ·Phase: PHASE4